• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Industrials·BANKA.NS
Share

Banka BioLoo Limited Stocks

₹ 66.87Last Updated 19.10.2026

Issuer Rating

3/7
Performance

Modest

Risk

Considerable

Recommendation

Sell

Market Cap

₹ 8.11M

₹ 66.87
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Banka BioLoo Limited is an Indian enterprise offering a comprehensive suite of products and services for sanitation and waste management. A key aspect of its operations involves the design, provision, and deployment of bio-toilets. Beyond installation, it takes responsibility for the ongoing operation and upkeep of bio-toilets, notably for Indian Railways. Its expertise further extends to the construction of both fecal sludge and packaged sewage treatment facilities, alongside the refurbishment of existing sewage treatment plants for various complexes. Established in 2012, Banka BioLoo is headquartered in Hyderabad, India.

Company Valuation

Overvalued
2/7

Considering past and projected metrics, the stock is 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, of fair value on EV/EBITDA, overval

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

21.10.2026 15:51

It's Not Just the War: Morgan Stanley Doesn't Expect the Fuel Market to Ease Until Mid-2027

21.10.2026 15:46

Morning in New York: Stress Tests for the Tech Sector Continue

21.10.2026 15:46

Losses Exceeding $80 Billion and Rapidly Rising Costs: What the WSJ Learned from Anthropic's Prospectus

21.10.2026 14:58

Where Can You Drive the Tesla Roadster? This and Other Questions About Musk's "Rocket on Wheels"

21.10.2026 14:36

France's borrowing costs have reached 5%. Is there a risk of a "Eurozone 2.0" crisis?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026